Skip to content

    BASF India

    BASFMixed
    Chemicals·26 May 2025
    Management Summary

    BASF India delivered a resilient top-line performance for FY25 with 11% volume-led growth, but faced severe margin compression in Q4. Profitability was hit by a 'double whammy' of higher input costs and an inability to pass these on due to aggressive Chinese dumping and overcapacity. While the company maintains a strong cash position and has increased dividends, management remains cautious about the near-term outlook for the chemical sector.

    Highlights

    8

    • Annual Revenue reached ₹15,000 crores, marking an 11% YoY growth driven entirely by volume.

    • Q4 PBT (before exceptional items) collapsed by nearly 90% to ₹25 crores from ₹219 crores YoY.

    • Full-year profitability declined by approximately 20% due to lower price realizations and higher input costs.

    • Agricultural Solutions segment profit fell to ₹311 crores from ₹436 crores in the previous year.

    • Materials segment emerged as the largest contributor, accounting for nearly one-third of total sales at ₹4,900 crores.

    • Recommended a dividend of 200% (₹86 crores total payout) compared to 150% in the previous year.

    • Inventory levels rose significantly, with over ₹700 crores of the increase attributed to the Agricultural segment.

    • Consolidated EPS (before exceptional items) stood at ₹105 per share.

    Concerns

    2

    • Chinese Overcapacity and Dumping

    • Margin Compression in Industrial Solutions

    What Changed2

    vs Q2 FY26

    Tone shiftNeutral → MixedGuidance items5 → 3 (-2)
    Key financials

    Metrics

    6

    Periods

    2

    Headline

    5
    • Revenue
      ₹15,000 Cr
      YoY+11%QoQ-13%
    • EPS (Consolidated)
      ₹105
    • ROI
      18.4%
      YoY-29.0%
    • Inventory Days
      72 days
    • Cash Balance
      ₹1,300 Cr

    Q4

    1
    • PBT (pre-exceptional)
      ₹25 Cr
      YoY-88.6%

    Segment breakdown

    Materials
    ₹4,900 Cr Revenue₹820 Cr Revenue Growth33.3% Sales Share
    Agricultural Solutions
    ₹311 Cr Annual Profit₹125 Cr Profit Decline14% Sales Share
    Nutrition and Care
    19% Sales Share
    List

    Guidance & targets

    3
    CategoryTargetPriority
    Dividend
    Dividend Payout Ratio
    200%
    		High
    Capacity
    OMP (Own Manufactured Product) Share
    Gradual increase from 50%
    		Medium
    Capex
    Celesto Project Completion
    Ongoing (1/3 spent)
    		Medium

    Risks & concerns

    6
    RiskSeverity

    Chinese Overcapacity and Dumping

    Aggressive pricing from China is preventing price pass-through despite rising input costs. — Both acknowledged

    high

    Inventory Buildup in Agro

    ₹700 crore increase in agro inventory due to a weak 'rabbi' season and high channel stocks. — Analyst acknowledged

    medium

    Margin Compression in Industrial Solutions

    Margins in materials and industrial solutions fell from ~10% to nearly 3%. — Management acknowledged

    high

    Areas of Evasion(3)

    • Future Capex numbers
    • Segment-specific ROCE targets
    • Specific timeline for China recovery

    Q&A highlights

    3

    “higher input cost but selling price could not be increased and hence the result so there's no dichotomy there”

    Confirms the company's lack of pricing power in the current environment due to global supply gluts.

    asked by Rohit Nagraj

    2 min read5 chapters

    Detailed Narrative

    01

    Q4 Profitability Crisis

    BASF India witnessed a dramatic 90% decline in Q4 PBT (before exceptional item📎s), falling to just ₹25 crores. This was driven by a volatile market where input costs remained high while selling prices were stagnant or lower. Management noted that while volumes grew, the inability to pass on costs led to the worst quarterly performance in the last eight quarters.

    02

    The China Overcapacity Shadow

    The chemical sector continues to reel under pressure from overcapacities built in China. Management highlighted that Chinese volumes are entering India at 'very aggressive price levels,' particularly impacting the upstream chemicals and plastic additives businesses. There is currently no visible sign of a 'substantial improvement' in this situation, making it a persistent headwind for margins.

    03

    Agricultural Solutions Headwinds

    The Agro segment faced a difficult 'rabbi' season characterized by low pest pressure and high channel inventories. This resulted in a ₹125 crore profit decline for the segment and a significant inventory spike of over ₹700 crores. To manage this, the company opted to take product back from the channel rather than extending payment terms, prioritizing balance sheet health over short-term sales.

    04

    Strategic Shift to Own Manufacturing

    A key strategic pillar for BASF India is increasing the share of 'Own Manufactured Products' (OMP). Currently, OMP stands at 44% of sales, with the remaining 56% coming from merchandise (trading). Management aims to steadily increase this ratio to improve margins and indigenize the portfolio, supported by investments like the Celesto expansion in the performance materials business.

    05

    Working Capital and Cash Management

    Despite the profit crunch, the company maintained a strong cash balance of ₹1,200-1,300 crores as of March 2025. Receivables have been kept under tight control despite an 11% increase in operations. However, cash flow from operations was significantly lower this year due to increased working capital needs, primarily driven by the inventory buildup in the agricultural segment.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.